Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-316-1 | CAS number: 1809-19-4
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Not mutagenic
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Not mutagenic
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
The substance is not considered to have mutagenic potential based on negative results in the Ames test, chromosomal aberration test and a mouse lymphoma assay, performed on the substance itself. Additionally, Ames tests, chromosomal aberration tests aa micronucleus test on structural analogues supported the findings on the substance. An in vivo chromosome aberration study on a structural analogue demonstrates that the substance is not mutagenic also in vivo.
Justification for classification or non-classification
All tests for genotoxicity are negative. No classification for mutagenicity is warranted under CLP Regulation EC no. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
